{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:44:35Z","timestamp":1792727075314,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.autrev.2016.07.024","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T22:31:08Z","timestamp":1470177068000},"page":"937-942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Multiparametric serological testing in autoimmune encephalitis using computer-aided immunofluorescence microscopy (CAIFM)"],"prefix":"10.1016","volume":"15","author":[{"given":"Johanna","family":"Fraune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Rentzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Teegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Lederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Affeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maick","family":"Danckwardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"St\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.07.024_bb0005","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2016.07.024_bb0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11060-004-1723-1","article-title":"T cell response to Hu-D peptides in patients with anti-Hu syndrome","volume":"71","author":"Rousseau","year":"2005","journal-title":"J Neurooncol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11864-013-0249-1","article-title":"Diagnosis and management of paraneoplastic neurologic disorders","volume":"14","author":"Rosenfeld","year":"2013","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0040","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2016.07.024_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0050","first-page":"329","article-title":"New serological markers for the differential diagnosis of autoimmune limbic encephalitis","volume":"35","author":"Wandinger","year":"2011","journal-title":"J Lab Med"},{"key":"10.1016\/j.autrev.2016.07.024_bb0055","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/neuonc\/nou030","article-title":"Autoimmune encephalitis update","volume":"16","author":"Dalmau","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0060","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2016.07.024_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0070","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","volume":"62","author":"Thieben","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0075","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2016.07.024_bb0080","article-title":"Autoimmune channelopathies: new antibody-mediated disorders of the central nervous system. F1000","volume":"1","author":"Vincent","year":"2009","journal-title":"Biol Reprod"},{"key":"10.1016\/j.autrev.2016.07.024_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0095","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies","volume":"82","author":"Balint","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0100","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","author":"Tobin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0105","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","article-title":"Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons","volume":"85","author":"Piepgras","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0115","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0120","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"Hoftberger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2013.04.004","article-title":"GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis","volume":"259","author":"Mundiyanapurath","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0135","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e3181d3e404","article-title":"The expanding clinical profile of anti-AMPA receptor encephalitis","volume":"74","author":"Graus","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0140","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens - pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0145","first-page":"366","article-title":"Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis","volume":"18","author":"Rosenfeld","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.autrev.2016.07.024_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.msard.2013.12.001","article-title":"Anti-neuronal autoantibodies: current diagnostic challenges","volume":"3","author":"Probst","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2016.07.024_bb0155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0160","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0165","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/jnnp.2010.229104","article-title":"Antiglycine-receptor encephalomyelitis with rigidity","volume":"82","author":"Mas","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2016.07.024_bb0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM200001063420104","article-title":"Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor","volume":"342","author":"Sillevis Smitt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.07.024_bb0175","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0180","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1212\/WNL.0000000000000865","article-title":"Limbic encephalitis with mGluR5 antibodies and immunotherapy-responsive prosopagnosia","volume":"83","author":"Pruss","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0185","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.23550","article-title":"Identification of delta\/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration","volume":"71","author":"de Graaff","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0190","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","article-title":"Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients","volume":"58","author":"Honnorat","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/jnnp.71.1.100","article-title":"Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases","volume":"71","author":"Meinck","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2016.07.024_bb0200","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2016.07.024_bb0205","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2016.07.024_bb0210","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0215","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1212\/WNL.0000000000001493","article-title":"Neuronal Na+\/K+ ATPase is an autoantibody target in paraneoplastic neurologic syndrome","volume":"84","author":"Scharf","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.07.024_bb0220","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00115-012-3607-5","article-title":"Autoantik\u00f6rperdiagnostik in der Neurologie mittels nativer und rekombinanter Antigensubstrate","volume":"84","author":"St\u00f6cker","year":"2013","journal-title":"Nervenarzt"},{"key":"10.1016\/j.autrev.2016.07.024_bb0225","doi-asserted-by":"crossref","first-page":"651058","DOI":"10.1155\/2012\/651058","article-title":"Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells","volume":"2012","author":"Voigt","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0230","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/0961203314559635","article-title":"EUROPattern Suite technology for computer-aided immunofluorescence microscopy in autoantibody diagnostics","volume":"24","author":"Krause","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.07.024_bb0235","series-title":"American College of Rheumatology position statement: methodology of testing for antinuclear antibodies","first-page":"1","author":"American College of Rheumatology","year":"2009"},{"key":"10.1016\/j.autrev.2016.07.024_bb0240","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014\u20132015","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0245","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1309\/Y5VF-C3DM-L8XV-U053","article-title":"Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases","volume":"117","author":"Tozzoli","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2016.07.024_bb0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13317-012-0035-2","article-title":"Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory","volume":"3","author":"Tozzoli","year":"2012","journal-title":"Autoimmun Highlights"},{"key":"10.1016\/j.autrev.2016.07.024_bb0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/cclm-2012-0191","article-title":"Current state of diagnostic technologies in the autoimmunology laboratory","volume":"51","author":"Tozzoli","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2016.07.024_bb0260","doi-asserted-by":"crossref","first-page":"742402","DOI":"10.1155\/2015\/742402","article-title":"Automated evaluation of Crithidia luciliae based indirect immunofluorescence tests: a novel application of the EUROPattern-Suite Technology","volume":"2015","author":"Gerlach","year":"2015","journal-title":"J Immunol Res"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T20:52:14Z","timestamp":1536526334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216301690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1568997216301690"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.07.024","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiparametric serological testing in autoimmune encephalitis using computer-aided immunofluorescence microscopy (CAIFM)","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}